RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,082,850 | -21.6% | 4,885,000 | +17.1% | 0.66% | -11.4% |
| Q2 2023 | $52,385,248 | -23.8% | 4,170,800 | -0.0% | 0.75% | -25.1% |
| Q1 2023 | $68,722,722 | +9.4% | 4,172,600 | -0.8% | 1.00% | +19.5% |
| Q4 2022 | $62,820,011 | -33.2% | 4,204,820 | 0.0% | 0.83% | -38.2% |
| Q3 2022 | $94,062,000 | +39.3% | 4,204,820 | +4.3% | 1.35% | +41.4% |
| Q2 2022 | $67,541,000 | -42.4% | 4,032,262 | +2.9% | 0.96% | -29.9% |
| Q1 2022 | $117,295,000 | -7.0% | 3,918,962 | -4.6% | 1.36% | +4.8% |
| Q4 2021 | $126,094,000 | +6.5% | 4,105,962 | +9.3% | 1.30% | +8.2% |
| Q3 2021 | $118,426,000 | +22.6% | 3,755,962 | +42.2% | 1.20% | +27.5% |
| Q2 2021 | $96,633,000 | +44.7% | 2,640,962 | +36.7% | 0.94% | +33.6% |
| Q1 2021 | $66,767,000 | +14.0% | 1,931,344 | +37.0% | 0.71% | +5.2% |
| Q4 2020 | $58,573,000 | +5.8% | 1,409,357 | +8.4% | 0.67% | -12.3% |
| Q3 2020 | $55,367,000 | – | 1,300,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |